Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Services for Patients and Care Givers

Glivec® International Patient Assistance Program (GIPAP)

Logo Max FoundationThe Glivec® International Patient Assistance Program (GIPAP) run by THE MAX Foundation in cooperation with Novartis is one of the most comprehensive and far-reaching cancer access programs ever developed on a global scale. Since its implementation in early 2002, GIPAP has provided Glivec® to more than 49,000 patients in 80 developing countries with minimal reimbursement capabilities who would not otherwise have access to the drug to treat their life-threatening diseases.